NEW YORK, Oct. 10, 2018 /PRNewswire/ -- ARYA Sciences Acquisition Corp. ("ARYA" or the "Company"), announced today that it closed its initial public offering of 14,375,000 units at $10.00 per unit. This includes the exercise in full of the underwriters' over-allotment option to purchase up to an additional 1,875,000 units. The sponsor of ARYA is ARYA Sciences Holdings, which is controlled by principals of Perceptive Advisors, LLC. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share. The units are listed on The Nasdaq Capital Market under the symbol "ARYAU".
Jefferies LLC acted as the sole book-running manager and Chardan acted as the lead manager for the offering.
A registration statement relating to these securities was declared effective by the SEC on October 4, 2018.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The registration statement ARYA has filed with the SEC can be obtained by visiting EDGAR on the SEC website at www.sec.gov.
The offering was made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, New York 10022, or by telephone at 877-547-6340, or by email at Prospectus_Department@Jefferies.com.
We are a newly organized blank check company newly incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with respect to identifying any business combination target.
Forward Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Chief Financial Officer of ARYA Sciences Acquisition Corp.
View original content:http://www.prnewswire.com/news-releases/arya-sciences-acquisition-corp-announces-closing-of-143-750-000-initial-public-offering-including-full-exercise-of-the-underwriters-over-allotment-option-300728710.html